Lisdexamfetamine
Lisdexamfetamine is a pharmaceutical drug with 27 clinical trials. Currently 1 active trials ongoing. Historical success rate of 71.4%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
4
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
65.2%
15 of 23 finished
34.8%
8 ended early
1
trials recruiting
27
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Trial to Assess How Centanafadine Interacts With Stimulants in the Body
A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes
IMProving Executive Function Study
An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
Clinical Trials (27)
A Trial to Assess How Centanafadine Interacts With Stimulants in the Body
A Study on Suicidality, Psychosis or Substance Abuse With Methylphenidate, Atomoxetine, Amphetamine/Dextroamphetamine or Lisdexamfetamine
Lisdexamphetamine Vs Methylphenidate for Pediatric Patients with ADHD and Type 1 Diabetes
IMProving Executive Function Study
An fMRI Study of Stimulant vs. Non-Stimulant Treatment of ADHD
Imaging the Effects of Stimulant Medication on Emotional Lability in Patients With ADHD
Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT
The Use of Lisdexamfetamine for Children Aged 7-13 With Attention Deficit Disorders
Treatment of Traumatic Brain Injury (TBI)-Related Attention Deficits in Children
Lisdexamfetamine's Effect In ADHD in the Brain and Cognition
Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence
Pharmacokinetics of Lisdexamfetamine (Vyvanse®) in Post-bariatric Surgery Patients
LDX and Functional Magnetic Resonance Imaging (fMRI in Menopausal Women
Neurobiological Basis of Response to Vyvanse in Adults With ADHD: an fMRI Study of Brain Activation
Characterization and Sequential Pharmacotherapy of Severe Mood Dysregulation
LDX for the Treatment of Cognitive Functioning Issues in Women Post-Oophorectomy
Clinical Efficacy of Lisdexamfetamine for Methamphetamine Dependence
Attention & Memory Impairments in Menopausal Women
E2 and LDX for the Treatment of Cognitive Complaints After Oophorectomy
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 27